Press Release – New York, NY – May 19, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma Inc., a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, in the company’s recent public offering of up to $18 million.
The SRFC team was led by partners Gregory Sichenzia and Jeff Cahlon, with associate Gary Eaton.